History Repeats: Will US Stelara Settlements Follow Humira’s Lead?

Adalimumab Example Could Provide A Playbook For Settlements Over Ustekinumab Biosimilars

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.